IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,408,520 | +10.6% | 2,169,500 | 0.0% | 2.09% | +29.6% |
| Q2 2023 | $89,014,585 | +17.2% | 2,169,500 | +2.1% | 1.61% | +8.2% |
| Q1 2023 | $75,929,630 | +0.8% | 2,124,500 | +6.6% | 1.49% | +3.5% |
| Q4 2022 | $75,298,272 | +121.4% | 1,993,600 | +159.3% | 1.44% | +128.2% |
| Q3 2022 | $34,008,000 | +102.6% | 768,900 | +69.6% | 0.63% | +107.6% |
| Q2 2022 | $16,785,000 | +159.9% | 453,400 | +324.1% | 0.30% | +230.4% |
| Q4 2019 | $6,458,000 | – | 106,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |